List of Tables
Table 1. Blood Plasma Derivatives Market Trends
Table 2. Blood Plasma Derivatives Market Drivers & Opportunity
Table 3. Blood Plasma Derivatives Market Challenges
Table 4. Blood Plasma Derivatives Market Restraints
Table 5. Global Blood Plasma Derivatives Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Blood Plasma Derivatives Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Blood Plasma Derivatives Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Blood Plasma Derivatives Product Type
Table 9. Key Companies Time to Begin Mass Production of Blood Plasma Derivatives
Table 10. Global Blood Plasma Derivatives Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Blood Plasma Derivatives Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Blood Plasma Derivatives Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Blood Plasma Derivatives Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Blood Plasma Derivatives Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Blood Plasma Derivatives Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Blood Plasma Derivatives Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Blood Plasma Derivatives Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Blood Plasma Derivatives Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Blood Plasma Derivatives Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Blood Plasma Derivatives Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Blood Plasma Derivatives Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Blood Plasma Derivatives Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Blood Plasma Derivatives Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Blood Plasma Derivatives Sales Value by Region (2019-2024) & (%)
Table 27. Global Blood Plasma Derivatives Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Blood Plasma Derivatives Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Blood Plasma Derivatives Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Blood Plasma Derivatives Sales Value, (2025-2030) & (US$ Million)
Table 31. Grifols Basic Information List
Table 32. Grifols Description and Business Overview
Table 33. Grifols Blood Plasma Derivatives Products, Services and Solutions
Table 34. Revenue (US$ Million) in Blood Plasma Derivatives Business of Grifols (2019-2024)
Table 35. Grifols Recent Developments
Table 36. SK Plasma Basic Information List
Table 37. SK Plasma Description and Business Overview
Table 38. SK Plasma Blood Plasma Derivatives Products, Services and Solutions
Table 39. Revenue (US$ Million) in Blood Plasma Derivatives Business of SK Plasma (2019-2024)
Table 40. SK Plasma Recent Developments
Table 41. Fusion Health Care Basic Information List
Table 42. Fusion Health Care Description and Business Overview
Table 43. Fusion Health Care Blood Plasma Derivatives Products, Services and Solutions
Table 44. Revenue (US$ Million) in Blood Plasma Derivatives Business of Fusion Health Care (2019-2024)
Table 45. Fusion Health Care Recent Developments
Table 46. Biotest AG Basic Information List
Table 47. Biotest AG Description and Business Overview
Table 48. Biotest AG Blood Plasma Derivatives Products, Services and Solutions
Table 49. Revenue (US$ Million) in Blood Plasma Derivatives Business of Biotest AG (2019-2024)
Table 50. Biotest AG Recent Developments
Table 51. Green Cross Corporation Basic Information List
Table 52. Green Cross Corporation Description and Business Overview
Table 53. Green Cross Corporation Blood Plasma Derivatives Products, Services and Solutions
Table 54. Revenue (US$ Million) in Blood Plasma Derivatives Business of Green Cross Corporation (2019-2024)
Table 55. Green Cross Corporation Recent Developments
Table 56. Baxter International Basic Information List
Table 57. Baxter International Description and Business Overview
Table 58. Baxter International Blood Plasma Derivatives Products, Services and Solutions
Table 59. Revenue (US$ Million) in Blood Plasma Derivatives Business of Baxter International (2019-2024)
Table 60. Baxter International Recent Developments
Table 61. LFB Basic Information List
Table 62. LFB Description and Business Overview
Table 63. LFB Blood Plasma Derivatives Products, Services and Solutions
Table 64. Revenue (US$ Million) in Blood Plasma Derivatives Business of LFB (2019-2024)
Table 65. LFB Recent Developments
Table 66. Octapharma AG Basic Information List
Table 67. Octapharma AG Description and Business Overview
Table 68. Octapharma AG Blood Plasma Derivatives Products, Services and Solutions
Table 69. Revenue (US$ Million) in Blood Plasma Derivatives Business of Octapharma AG (2019-2024)
Table 70. Octapharma AG Recent Developments
Table 71. CSL Limited Basic Information List
Table 72. CSL Limited Description and Business Overview
Table 73. CSL Limited Blood Plasma Derivatives Products, Services and Solutions
Table 74. Revenue (US$ Million) in Blood Plasma Derivatives Business of CSL Limited (2019-2024)
Table 75. CSL Limited Recent Developments
Table 76. Takeda Basic Information List
Table 77. Takeda Description and Business Overview
Table 78. Takeda Blood Plasma Derivatives Products, Services and Solutions
Table 79. Revenue (US$ Million) in Blood Plasma Derivatives Business of Takeda (2019-2024)
Table 80. Takeda Recent Developments
Table 81. China Biologic Products Basic Information List
Table 82. China Biologic Products Description and Business Overview
Table 83. China Biologic Products Blood Plasma Derivatives Products, Services and Solutions
Table 84. Revenue (US$ Million) in Blood Plasma Derivatives Business of China Biologic Products (2019-2024)
Table 85. China Biologic Products Recent Developments
Table 86. Kedrion Biopharma Basic Information List
Table 87. Kedrion Biopharma Description and Business Overview
Table 88. Kedrion Biopharma Blood Plasma Derivatives Products, Services and Solutions
Table 89. Revenue (US$ Million) in Blood Plasma Derivatives Business of Kedrion Biopharma (2019-2024)
Table 90. Kedrion Biopharma Recent Developments
Table 91. BDI Pharma Basic Information List
Table 92. BDI Pharma Description and Business Overview
Table 93. BDI Pharma Blood Plasma Derivatives Products, Services and Solutions
Table 94. Revenue (US$ Million) in Blood Plasma Derivatives Business of BDI Pharma (2019-2024)
Table 95. BDI Pharma Recent Developments
Table 96. Bayer AG Basic Information List
Table 97. Bayer AG Description and Business Overview
Table 98. Bayer AG Blood Plasma Derivatives Products, Services and Solutions
Table 99. Revenue (US$ Million) in Blood Plasma Derivatives Business of Bayer AG (2019-2024)
Table 100. Bayer AG Recent Developments
Table 101. Hualan Biological Engineering Basic Information List
Table 102. Hualan Biological Engineering Description and Business Overview
Table 103. Hualan Biological Engineering Blood Plasma Derivatives Products, Services and Solutions
Table 104. Revenue (US$ Million) in Blood Plasma Derivatives Business of Hualan Biological Engineering (2019-2024)
Table 105. Hualan Biological Engineering Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Blood Plasma Derivatives Downstream Customers
Table 109. Blood Plasma Derivatives Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Blood Plasma Derivatives Product Picture
Figure 2. Global Blood Plasma Derivatives Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
Figure 4. Blood Plasma Derivatives Report Years Considered
Figure 5. Global Blood Plasma Derivatives Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Blood Plasma Derivatives Revenue in 2023
Figure 7. Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Albumin Picture
Figure 9. Factor VIII Picture
Figure 10. Factor IX Picture
Figure 11. Immunoglobulin Picture
Figure 12. Hyperimmune Globulin Picture
Figure 13. Others Picture
Figure 14. Global Blood Plasma Derivatives Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Blood Plasma Derivatives Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Hospitals
Figure 17. Product Picture of Clinics
Figure 18. Product Picture of Other End Users
Figure 19. Global Blood Plasma Derivatives Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Blood Plasma Derivatives Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Blood Plasma Derivatives Sales Value (%), (2019-2030)
Figure 32. United States Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
Figure 38. China Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
Figure 40. China Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
Figure 50. India Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
Figure 52. India Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
Figure 53. Blood Plasma Derivatives Industrial Chain
Figure 54. Blood Plasma Derivatives Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
